Innate Pharma SA annual operating margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
Innate Pharma SA Operating Margin Growth & History (IPHA)
Innate Pharma SA's operating margin was −599.76% for fiscal 2025.
View full Innate Pharma SA company overviewInnate Pharma SA annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −599.76% | −343.43 pp |
| 2024 | 2024-12-31 | −256.32% | −235.77 pp |
| 2023 | 2023-12-31 | −20.55% | +79.02 pp |
| 2022 | 2022-12-31 | −99.57% | +94.03 pp |
| 2021 | 2021-12-31 | −193.60% | −195.15 pp |
| 2020 | 2020-12-31 | 1.55% | −0.30 pp |
| 2019 | 2019-12-31 | 1.84% | −3.63 pp |
| 2018 | 2018-12-31 | 5.48% | +96.28 pp |
| 2017 | 2017-12-31 | −90.80% | — |
Innate Pharma SA quarterly operating margin
No reported data
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Innate Pharma SA operating margin trends
Over the last five reported fiscal years, Innate Pharma SA's operating margin decreased from 1.55% to −599.76%, a change of −601.30 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Innate Pharma SA filings at SEC.gov ↗